-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
New Quality Productive Forces Unleash New Momentum for Development: On-the-Ground Observations of Hebei’s Economy at the Start of the Year
Category:
发布时间：2025-01-15
【概要描述】
At the start of the year, driven by technological innovation, Hebei Province is witnessing robust growth in new-quality productive forces, with ongoing efforts to intelligently upgrade and digitally transform traditional industries, yielding new advances and a fresh outlook across multiple sectors.
At the start of the year, driven by technological innovation, Hebei Province is witnessing robust momentum in the development of new-quality productive forces, with ongoing efforts to intelligently upgrade and digitally transform traditional industries, yielding new advances and a fresh outlook across multiple sectors.
At Shijiazhuang Sihua Pharmaceutical Group, the research and development of a new nephrological drug has made significant progress and is currently in the preclinical stage. Leveraging the robust capabilities of its virtual screening and AI-driven drug discovery platform, the company is accelerating the translation of its innovative scientific achievements into clinical applications.
(Originally published on January 13 on Xinhuanet)
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091